LEADER 02678nam 2200397 450 001 9910583394903321 005 20230120002459.0 010 $a0-12-802625-1 035 $a(CKB)3710000001051658 035 $a(MiAaPQ)EBC4801368 035 $a(MiAaPQ)EBC5105688 035 $a(EXLCZ)993710000001051658 100 $a20190409d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aTranslational immunotherapy of brain tumors /$feditor, John H. Sampson 210 1$aLondon :$cAcademic Press, an imprint of Elsevier,$d[2017] 210 4$dİ2017 215 $a1 online resource (406 pages) $cillustrations 311 $a0-12-802420-8 320 $aIncludes bibliographical references and index. 327 $aAn introduction to immunotherapy in the treatment of brain tumors / J.M. Komisarow and J.H. Sampson -- Immune constitution of patients with brain tumors / J. Berry-Candelario, S.H. Farber and P.E. Fecci -- The role of regulatory t cells and indolamine-2,3-dioxygenase in brain tumor immunosuppresion / M. Dey, A.L. Chang, J. Miska, J. Qiao and M.S. Lesniak -- The role of myeloid-derived suppressor cells in immunosuppresion in brain tumors / K. Gabrusiewicz, N.A. Colwell, and A.B. Heimberger -- Tumor-specific mutations in gliomas and their implications for immunotherapy / C.J. Pirozzi, A.B. Carpenter, T. Hennika, O.J. Becher and H. Yan -- Preclinical immunotherapeutic animal models fo brain tumors / V. Chandramohan, L. Sanchez-Perez, Y. He, C.J. Pirozzi, K.L. Congdon and D.D. Bigner -- Imaging studies in immunotherapy / R.Y. Huang and D.A. Reardon -- Immunotherapy clinical trials in neuro-oncology / S. Khagi and G. Vlahovic -- Peptide-specific vaccines / P. Roth and M. Weller -- Immunotoxin therapy for brain tumors / V. Chandramohan, J.H. Sampson, I.H. Pastan and D.D. Bigner -- Checkpoint blockade immunotherapy for glioblastoma / K.A. Riccione, P. Gedeon, L. Sanchez-Perez and J.H. Sampson -- Dendritic cell therapy for brain tumors / R.G. Everson, J.P. Antonios, A.M. Tucker and L.M. Liau -- Adoptive immunotherapy against brain tumors / C. Flores, D. Mitchell and P.A. Wells -- Chimeric antigen receptor therapy of brain tumors / L. Sanchez-Perez, C.M. Suryadevara, B.D. Choi and L.A. Johnson. 606 $aBrain$xTumors$xImmunotherapy 615 0$aBrain$xTumors$xImmunotherapy. 676 $a616.99/481 702 $aSampson$b John H. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910583394903321 996 $aTranslational immunotherapy of brain tumors$92049701 997 $aUNINA LEADER 01495nas 2200361 u 450 001 9910327258903321 005 20241204171802.0 011 $a2241-7958 024 7 $a10.30958/aje 035 $a(CKB)12222311900041 035 $a(EXLCZ)9912222311900041 100 $a20190702a2014 || | 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAthens Journal of Education 210 1$aAthens, Greece :$cpublished by the Education Unit of ATINER,$d2014 300 $aRefereed/Peer-reviewed 300 $aTitle from journal's home page, viewed July 2, 2019. 311 0 $a2407-9898 330 $a"The Athens Journal of Education (AJE) is an Open Access quarterly double blind peer reviewed journal and considers papers from all areas of education. Many of the papers published in this journal have been presented at the various conferences sponsored by the Education Unit of the Athens Institute for Education and Research (ATINER). All papers are subject to ATINER?s Publication Ethical Policy and Statement."--$cFrom journal's website. 517 3 $aAJE 606 $aEducation$vPeriodicals$9lat$2NLI 606 $aEducation$vPeriodicals 615 7$aEducation 615 0$aEducation 712 02$aAthens Institute for Education and Research Business,$bEducation Unit 912 $a9910327258903321 996 $aAthens Journal of Education$92230118 997 $aUNINA 999 $aSER 999 $aEJOURNAL